 |
市場調查報告書
商品編碼
1157282
慢性靜脈閉塞症治療的世界市場規模:各產品，各用途，各最終用途，產業分析，地區預測，成長可能性，競爭的市場佔有率，預測(2022年～2030年)Chronic Venous Occlusions Treatment Market Size by Product, By Application, By End-Use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030 |
||||||
價格
全球慢性靜脈閉塞症治療的市場規模，由於需要手術的慢性靜脈閉塞症的流行，預計到2030年記錄很大的收益。
本報告提供全球慢性靜脈閉塞症治療市場相關調查分析，產業的考察，市場區隔分析，地區分析，企業簡介等資訊。
目錄
第1章 調查手法和範圍
第2章 摘要整理
第3章 慢性靜脈閉塞症治療產業的考察
- 產業市場區隔
- 產業形勢(2017年～2030年)
- 產業的影響要素
- 成長促進因素
- 產業的潛在的風險、課題
- 成長可能性分析
- 各產品
- 各用途
- 各最終用途
- COVID-19影響的分析
- 治療形勢
- 償付情境
- 流行病學情境
- 波特的五力分析
- 競爭情形(2021年)
- 企業矩陣分析(2021年)
- 大環境分析
第4章 慢性靜脈閉塞症治療市場:各產品
- 主要的市場區隔趨勢
- 設備
- 市場規模:各地區(2017年～2030年)
- 壓縮設備
- 靜脈內切除
- 硬化療法
- 靜脈剝線鉗
- 其他
- 藥物
- 市場規模:各地區(2017年～2030年)
- 止痛藥
- 抗生素
- 抗凝固劑
- 其他
第5章 慢性靜脈閉塞症治療市場:各用途
- 主要的市場區隔趨勢
- 靜脈瘤
- 靜脈鬱滯性潰瘍
- 水腫
- 深層靜脈栓塞
- 其他
第6章 慢性靜脈閉塞症治療市場:各最終用途
- 主要的市場區隔趨勢
- 醫院
- 門診病人手術中心
- 其他
第7章 慢性靜脈閉塞症治療市場:各地區
- 主要地區趨勢
- 北美
- 市場規模:各國(2017年～2030年)
- 市場規模:各產品(2017年～2030年)
- 市場規模:各用途(2017年～2030年)
- 市場規模:各最終用途(2017年～2030年)
- 美國
- 加拿大
- 歐洲
- 市場規模:各國(2017年～2030年)
- 市場規模:各產品(2017年～2030年)
- 市場規模:各用途(2017年～2030年)
- 市場規模:各最終用途(2017年～2030年)
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 亞太地區
- 市場規模:各國(2017年～2030年)
- 市場規模:各產品(2017年～2030年)
- 市場規模:各用途(2017年～2030年)
- 市場規模:各最終用途(2017年～2030年)
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 南美
- 市場規模:各國(2017年～2030年)
- 市場規模:各產品(2017年～2030年)
- 市場規模:各用途(2017年～2030年)
- 市場規模:各最終用途(2017年～2030年)
- 巴西
- 墨西哥
- 阿根廷
- 中東、非洲
- 市場規模:各國(2017年～2030年)
- 市場規模:各產品(2017年～2030年)
- 市場規模:各用途(2017年～2030年)
- 市場規模:各最終用途(2017年～2030年)
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
第8章 企業簡介
- 競爭儀表板(2021年)
- Boston Scientific Corporation
- Stryker Corporation
- AngioDynamics
- Bristol Myers Squibb
- Sanofi
- Bayer AG
- Medtronic plc
- Pfizer Inc.
- ISOMed
- Cardinal Health
- SerenaGroup
- Tactile Medical
- ArjoHuntleigh
- Essity AB
- Julius Zorn GmbH
- Smith & Nephew PLC
- Viatris Inc.
- Merz Pharma
- QOL Medical
- Candela
- Sciton, Inc
- Fotona
- 3M Company
- ConvaTec Inc.
- Medi GmbH & Co. KG
- Sigvaris AG
- Leucadia Pharmaceuticals (Hikma)
- Lumenis Ltd.
- Venclose, Inc. (Becton Dickinson and Company
Product Code: 5398
Global Chronic Venous Occlusions Treatment Market share is foreseen to record significant proceeds through 2030 owing to the growing prevalence of chronic venous occlusion ailments that require surgical attention. As per orpha.net statistics, hepatic veno-occlusive disease develops in 0.3 per cent to 2.3 per cent of patients who receive liver transplant, in 15% of patients treated with gemtuzumab ozogamicin, with statistics projected to rise to 40% in those with a history of GO treatment.
Factors like ongoing research studies and technological developments in deep vein thrombosis treatment would contribute to the growing market landscape between 2022-2030. In 2021, Penn State College of Engineering researchers developed an imaging technique that could become the treatment for deep vein thrombosis.
The overall market is segmented into products, applications, end-use, and regions.
Based on the product bifurcation, the devices segment is likely to amass substantial gains over 2022-2030. Mounting demand for advanced therapeutic and medical devices on grounds of their multiple advantages would contribute to the segmental expansion. Besides, the use of chronic venous occlusions treatment devices aids in controlling and preventing blood clots while increasing blood flow in legs.
In terms of application, chronic venous occlusions treatment market share from varicose veins segment is slated to surge considerably by 2030 end. Rising prevalence of varicose veins worldwide would prompt the product demand. Globally, the frequency varies between 10% to 30% of the population. Meanwhile, in the US, the prevalence is around 4,500 in 100,000 people. Numerous merits offered by the available treatment alternatives for chronic venous occlusion in treatment of varicose veins would stimulate the market prospects.
On basis of end-use, the hospitals segment is observing positive growth in the global market due to the rising adoption of technologically advanced venous devices and the availability of minimally invasive treatment options. Furthermore, the presence of medical professionals with high expertise and skills in target disorder treatment would complement the chronic venous occlusions treatment market growth trajectory between 2022-2030.
Geographically, North America chronic venous occlusions treatment market size is predicted to rise meteorically. In 2021, the regional market captured a more than 40% business share and would expand further at a notable rate through 2030. The growth would come from the elevating prevalence of chronic venous diseases, presence of major players in the continent, and reimbursement medical policies across North America.
The chronic venous occlusions treatment industry is highly consolidated and boasts presence of leading companies such as Sanofi, Boston Scientific Corporation, Bayer AG, Stryker Corporation, Bristol Myers Squibb, Cardinal Health, Tactile Medical, Pfizer Inc., and Medtronic plc, amongst others. These conglomerates are engaged in business tactics including acquisitions, mergers, partnerships, and product launches to gain a competitive advantage over others.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definitions
- 1.2 Base estimates and working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
- 1.5.1 Secondary
Chapter 2 Executive Summary
- 2.1 Chronic venous occlusions treatment industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Chronic Venous Occlusions Treatment Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030 (USD Million)
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Increasing prevalence of varicose veins coupled with rising awareness regarding its treatment
- 3.3.1.2 Growing preference for minimally invasive procedures
- 3.3.1.3 Rise in number of orthopedic procedures
- 3.3.1.4 Technological advancements pertaining to chronic venous insufficiency treatment therapies
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Side effects and risks associated with different treatment modes
- 3.3.2.2 Strict regulatory guidelines
- 3.3.1 Growth drivers
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By end-use
- 3.5 COVID- 19 impact analysis
- 3.6 Treatment landscape
- 3.7 Reimbursement scenario
- 3.8 Epidemiology scenario
- 3.9 Porter's analysis
- 3.9.1 Industry rivalry
- 3.9.2 Suppliers power
- 3.9.3 Buyer power
- 3.9.4 Threat of substitute
- 3.9.5 Threat of new entrants
- 3.10 Competitive landscape, 2021
- 3.10.1 Company matrix analysis, 2021
- 3.11 PESTLE analysis
- 3.11.1 Political
- 3.11.2 Economical
- 3.11.3 Social
- 3.11.4 Technological
- 3.11.5 Legal
- 3.11.6 Environmental
Chapter 4 Chronic Venous Occlusions Treatment Market, By Product
- 4.1 Key segment trends
- 4.2 Devices
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.2 Compression Devices
- 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.3 Endovenous Ablation
- 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.3.2 Laser Ablation
- 4.2.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.3.3 Radiofrequency Ablation
- 4.2.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.4 Sclerotherapy
- 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.5 Vein stripper
- 4.2.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.6 Others
- 4.2.6.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Drugs
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.2 Analgesics
- 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.3 Antibiotics
- 4.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.4 Anticoagulants
- 4.3.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.5 Others
- 4.3.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Chronic Venous Occlusions Treatment Market, By Application
- 5.1 Key segment trends
- 5.2 Varicose Veins
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Venous Stasis Ulcers
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Edema
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.5 Deep Vein Thrombosis
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.6 Others
- 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Chronic Venous Occlusions Treatment Market, By End-use
- 6.1 Key segment trends
- 6.2 Hospitals
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Ambulatory surgical centers
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 Others
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Chronic Venous Occlusions Treatment Market, By Region
- 7.1 Key regional trends
- 7.2 North America
- 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.2.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.2.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.2.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.5 U.S.
- 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.2.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.2.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.6 Canada
- 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.2.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.2.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.3.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.3.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.3.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.5 Germany
- 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.3.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.3.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.6 UK
- 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.3.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.3.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.7 France
- 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.3.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.3.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.8 Spain
- 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.8.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.3.8.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.3.8.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.9 Italy
- 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.9.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.3.9.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.3.9.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.4.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.4.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.4.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.5 China
- 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.4.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.4.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.6 Japan
- 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.4.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.4.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.7 India
- 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.4.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.4.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.8 Australia
- 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.8.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.4.8.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.4.8.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.9 South Korea
- 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.9.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.4.9.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.4.9.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5 Latin America
- 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.5.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.5.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.5.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.5 Brazil
- 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.5.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.5.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.6 Mexico
- 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.5.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.5.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.7 Argentina
- 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.5.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.5.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6 MEA
- 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.6.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.6.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.6.2.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.5 South Africa
- 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.6.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.6.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.6 Saudi Arabia
- 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.6.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.6.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.7 UAE
- 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
- 7.6.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
- 7.6.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
- 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Competitive dashboard, 2021
- 8.2 Boston Scientific Corporation
- 8.2.1 Business Overview
- 8.2.2 Financial Data
- 8.2.3 Product Landscape
- 8.2.4 Strategic Outlook
- 8.2.5 SWOT Analysis
- 8.3 Stryker Corporation
- 8.3.1 Business Overview
- 8.3.2 Financial Data
- 8.3.3 Product Landscape
- 8.3.4 Strategic Outlook
- 8.3.5 SWOT Analysis
- 8.4 AngioDynamics
- 8.4.1 Business Overview
- 8.4.2 Financial Data
- 8.4.3 Product Landscape
- 8.4.4 Strategic Outlook
- 8.4.5 SWOT Analysis
- 8.5 Bristol Myers Squibb
- 8.5.1 Business Overview
- 8.5.2 Financial Data
- 8.5.3 Product Landscape
- 8.5.4 Strategic Outlook
- 8.5.5 SWOT Analysis
- 8.6 Sanofi
- 8.6.1 Business Overview
- 8.6.2 Financial Data
- 8.6.3 Product Landscape
- 8.6.4 Strategic Outlook
- 8.6.5 SWOT Analysis
- 8.7 Bayer AG
- 8.7.1 Business Overview
- 8.7.2 Financial Data
- 8.7.3 Product Landscape
- 8.7.4 Strategic Outlook
- 8.7.5 SWOT Analysis
- 8.8 Medtronic plc
- 8.8.1 Business Overview
- 8.8.2 Financial Data
- 8.8.3 Product Landscape
- 8.8.4 Strategic Outlook
- 8.8.5 SWOT Analysis
- 8.9 Pfizer Inc.
- 8.9.1 Business Overview
- 8.9.2 Financial Data
- 8.9.3 Product Landscape
- 8.9.4 Strategic Outlook
- 8.9.5 SWOT Analysis
- 8.10 ISOMed
- 8.10.1 Business Overview
- 8.10.2 Financial Data
- 8.10.3 Product Landscape
- 8.10.4 Strategic Outlook
- 8.10.5 SWOT Analysis
- 8.11 Cardinal Health
- 8.11.1 Business Overview
- 8.11.2 Financial Data
- 8.11.3 Product Landscape
- 8.11.4 Strategic Outlook
- 8.11.5 SWOT Analysis
- 8.12 SerenaGroup
- 8.12.1 Business Overview
- 8.12.2 Financial Data
- 8.12.3 Product Landscape
- 8.12.4 Strategic Outlook
- 8.12.5 SWOT Analysis
- 8.13 Tactile Medical
- 8.13.1 Business Overview
- 8.13.2 Financial Data
- 8.13.3 Product Landscape
- 8.13.4 Strategic Outlook
- 8.13.5 SWOT Analysis
- 8.14 ArjoHuntleigh
- 8.14.1 Business Overview
- 8.14.2 Financial Data
- 8.14.3 Product Landscape
- 8.14.4 Strategic Outlook
- 8.14.5 SWOT Analysis
- 8.15 Essity AB
- 8.15.1 Business Overview
- 8.15.2 Financial Data
- 8.15.3 Product Landscape
- 8.15.4 Strategic Outlook
- 8.15.5 SWOT Analysis
- 8.16 Julius Zorn GmbH
- 8.16.1 Business Overview
- 8.16.2 Financial Data
- 8.16.3 Product Landscape
- 8.16.4 Strategic Outlook
- 8.16.5 SWOT Analysis
- 8.17 Smith & Nephew PLC
- 8.17.1 Business Overview
- 8.17.2 Financial Data
- 8.17.3 Product Landscape
- 8.17.4 Strategic Outlook
- 8.17.5 SWOT Analysis
- 8.18 Viatris Inc.
- 8.18.1 Business Overview
- 8.18.2 Financial Data
- 8.18.3 Product Landscape
- 8.18.4 Strategic Outlook
- 8.18.5 SWOT Analysis
- 8.19 Merz Pharma
- 8.19.1 Business Overview
- 8.19.2 Financial Data
- 8.19.3 Product Landscape
- 8.19.4 Strategic Outlook
- 8.19.5 SWOT Analysis
- 8.20 QOL Medical
- 8.20.1 Business Overview
- 8.20.2 Financial Data
- 8.20.3 Product Landscape
- 8.20.4 Strategic Outlook
- 8.20.5 SWOT Analysis
- 8.21 Candela
- 8.21.1 Business Overview
- 8.21.2 Financial Data
- 8.21.3 Product Landscape
- 8.21.4 Strategic Outlook
- 8.21.5 SWOT Analysis
- 8.22 Sciton, Inc
- 8.22.1 Business Overview
- 8.22.2 Financial Data
- 8.22.3 Product Landscape
- 8.22.4 Strategic Outlook
- 8.22.5 SWOT Analysis
- 8.23 Fotona
- 8.23.1 Business Overview
- 8.23.2 Financial Data
- 8.23.3 Product Landscape
- 8.23.4 Strategic Outlook
- 8.23.5 SWOT Analysis
- 8.24 3M Company
- 8.24.1 Business Overview
- 8.24.2 Financial Data
- 8.24.3 Product Landscape
- 8.24.4 Strategic Outlook
- 8.24.5 SWOT Analysis
- 8.25 ConvaTec Inc.
- 8.25.1 Business Overview
- 8.25.2 Financial Data
- 8.25.3 Product Landscape
- 8.25.4 Strategic Outlook
- 8.25.5 SWOT Analysis
- 8.26 Medi GmbH & Co. KG
- 8.26.1 Business Overview
- 8.26.2 Financial Data
- 8.26.3 Product Landscape
- 8.26.4 Strategic Outlook
- 8.26.5 SWOT Analysis
- 8.27 Sigvaris AG
- 8.27.1 Business Overview
- 8.27.2 Financial Data
- 8.27.3 Product Landscape
- 8.27.4 Strategic Outlook
- 8.27.5 SWOT Analysis
- 8.28 Leucadia Pharmaceuticals (Hikma)
- 8.28.1 Business Overview
- 8.28.2 Financial Data
- 8.28.3 Product Landscape
- 8.28.4 Strategic Outlook
- 8.28.5 SWOT Analysis
- 8.29 Lumenis Ltd.
- 8.29.1 Business Overview
- 8.29.2 Financial Data
- 8.29.3 Product Landscape
- 8.29.4 Strategic Outlook
- 8.29.5 SWOT Analysis
- 8.30 Venclose, Inc. (Becton Dickinson and Company
- 8.30.1 Business Overview
- 8.30.2 Financial Data
- 8.30.3 Product Landscape
- 8.30.4 Strategic Outlook
- 8.30.5 SWOT Analysis
Data Tables
- TABLE 1 Global chronic venous occlusions treatment market, 2017 - 2021 (USD Million)
- TABLE 2 Global chronic venous occlusions treatment market, 2022 - 2030 (USD Million)
- TABLE 3 Global chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 4 Global chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 5 Global chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 6 Global chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 7 Global chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 8 Global chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 9 Global chronic venous occlusions treatment market, by region, 2017 - 2021 (USD Million)
- TABLE 10 Global chronic venous occlusions treatment market, by region, 2022 - 2030 (USD Million)
- TABLE 11 Industry impact forces
- TABLE 12 Devices market, by region, 2017 - 2021, (USD Million)
- TABLE 13 Devices market, by region, 2022 - 2030, (USD Million)
- TABLE 14 Compression devices market, by region, 2017 - 2021, (USD Million)
- TABLE 15 Compression devices market, by region, 2022 - 2030, (USD Million)
- TABLE 16 Endovenous ablation market, by region, 2017 - 2021, (USD Million)
- TABLE 17 Endovenous ablation systems market, by region, 2022 - 2030, (USD Million)
- TABLE 18 Laser ablation market, by region, 2017 - 2021, (USD Million)
- TABLE 19 Laser ablation market, by region, 2022 - 2030, (USD Million)
- TABLE 20 Radiofrequency ablation market, by region, 2017 - 2021, (USD Million)
- TABLE 21 Radiofrequency ablation market, by region, 2022 - 2030, (USD Million)
- TABLE 22 Sclerotherapy market, by region, 2017 - 2021, (USD Million)
- TABLE 23 Sclerotherapy market, by region, 2022 - 2030, (USD Million)
- TABLE 24 Vein stripper market, by region, 2017 - 2021, (USD Million)
- TABLE 25 Vein stripper market, by region, 2022 - 2030, (USD Million)
- TABLE 26 Others market, by region, 2017 - 2021, (USD Million)
- TABLE 27 Others market, by region, 2022 - 2030, (USD Million)
- TABLE 28 Drugs market, by region, 2017 - 2021, (USD Million)
- TABLE 29 Drugs market, by region, 2022 - 2030, (USD Million)
- TABLE 30 Analgesics market, by region, 2017 - 2021, (USD Million)
- TABLE 31 Analgesics market, by region, 2022 - 2030, (USD Million)
- TABLE 32 Antibiotics market, by region, 2017 - 2021, (USD Million)
- TABLE 33 Antibiotics market, by region, 2022 - 2030, (USD Million)
- TABLE 34 Anticoagulants market, by region, 2017 - 2021, (USD Million)
- TABLE 35 Anticoagulants market, by region, 2022 - 2030, (USD Million)
- TABLE 36 Others market, by region, 2017 - 2021, (USD Million)
- TABLE 37 Others market, by region, 2022 - 2030, (USD Million)
- TABLE 38 Varicose veins market, by region, 2017 - 2021, (USD Million)
- TABLE 39 Varicose veins market, by region, 2022 - 2030, (USD Million)
- TABLE 40 Venous stasis ulcers market, by region, 2017 - 2021, (USD Million)
- TABLE 41 Venous stasis ulcers market, by region, 2022 - 2030, (USD Million)
- TABLE 42 Edema market, by region, 2017 - 2021, (USD Million)
- TABLE 43 Edema market, by region, 2022 - 2030, (USD Million)
- TABLE 44 Deep vein thrombosis market, by region, 2017 - 2021, (USD Million)
- TABLE 45 Deep vein thrombosis market, by region, 2022 - 2030, (USD Million)
- TABLE 46 Others market, by region, 2017 - 2021, (USD Million)
- TABLE 47 Others market, by region, 2022 - 2030, (USD Million)
- TABLE 48 Hospitals market, by region, 2017 - 2021, (USD Million)
- TABLE 49 Hospitals market, by region, 2022 - 2030, (USD Million)
- TABLE 50 Ambulatory surgical centers market, by region, 2017 - 2021, (USD Million)
- TABLE 51 Ambulatory surgical centers market, by region, 2022 - 2030, (USD Million)
- TABLE 52 Others market, by region, 2017 - 2021, (USD Million)
- TABLE 53 Others market, by region, 2022 - 2030, (USD Million)
- TABLE 54 North America chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
- TABLE 55 North America chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
- TABLE 56 North America chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 57 North America chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 58 North America chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 59 North America chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 60 North America chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 61 North America chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 62 North America chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 63 North America chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 64 North America chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 65 North America chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 66 North America chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 67 North America chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 68 U.S. chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 69 U.S. chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 70 U.S. chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 71 U.S. chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 72 U.S. chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 73 U.S. chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 74 U.S. chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 75 U.S. chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 76 U.S. chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 77 U.S. chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 78 U.S. chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 79 U.S. chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 80 Canada chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 81 Canada chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 82 Canada chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 83 Canada chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 84 Canada chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 85 Canada chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 86 Canada chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 87 Canada chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 88 Canada chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 89 Canada chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 90 Canada chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 91 Canada chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 92 Europe chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
- TABLE 93 Europe chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
- TABLE 94 Europe chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 95 Europe chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 96 Europe chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 97 Europe chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 98 Europe chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 99 Europe chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 100 Europe chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 101 Europe chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 102 Europe chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 103 Europe chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 104 Europe chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 105 Europe chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 106 Germany chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 107 Germany chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 108 Germany chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 109 Germany chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 110 Germany chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 111 Germany chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 112 Germany chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 113 Germany chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 114 Germany chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 115 Germany chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 116 Germany chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 117 Germany chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 118 UK chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 119 UK chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 120 UK chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 121 UK chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 122 UK chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 123 UK chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 124 UK chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 125 UK chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 126 UK chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 127 UK chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 128 UK chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 129 UK chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 130 France chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 131 France chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 132 France chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 133 France chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 134 France chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 135 France chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 136 France chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 137 France chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 138 France chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 139 France chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 140 France chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 141 France chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 142 Spain chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 143 Spain chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 144 Spain chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 145 Spain chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 146 Spain chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 147 Spain chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 148 Spain chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 149 Spain chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 150 Spain chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 151 Spain chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 152 Spain chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 153 Spain chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 154 Italy chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 155 Italy chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 156 Italy chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 157 Italy chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 158 Italy chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 159 Italy chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 160 Italy chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 161 Italy chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 162 Italy chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 163 Italy chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 164 Italy chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 165 Italy chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 166 Asia Pacific chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
- TABLE 167 Asia Pacific chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
- TABLE 168 Asia Pacific chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 169 Asia Pacific chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 170 Asia Pacific chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 171 Asia Pacific chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 172 Asia Pacific chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 173 Asia Pacific chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 174 Asia Pacific chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 175 Asia Pacific chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 176 Asia Pacific chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 177 Asia Pacific chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 178 Asia Pacific chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 179 Asia Pacific chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 180 China chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 181 China chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 182 China chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 183 China chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 184 China chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 185 China chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 186 China chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 187 China chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 188 China chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 189 China chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 190 China chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 191 China chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 192 Japan chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 193 Japan chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 194 Japan chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 195 Japan chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 196 Japan chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 197 Japan chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 198 Japan chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 199 Japan chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 200 Japan chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 201 Japan chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 202 Japan chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 203 Japan chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 204 India chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 205 India chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 206 India chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 207 India chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 208 India chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 209 India chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 210 India chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 211 India chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 212 India chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 213 India chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 214 India chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 215 India chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 216 Australia chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 217 Australia chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 218 Australia chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 219 Australia chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 220 Australia chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 221 Australia chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 222 Australia chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 223 Australia chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 224 Australia chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 225 Australia chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 226 Australia chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 227 Australia chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 228 South Korea chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 229 South Korea chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 230 South Korea chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 231 South Korea chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 232 South Korea chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 233 South Korea chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 234 South Korea chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 235 South Korea chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 236 South Korea chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 237 South Korea chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 238 South Korea chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 239 South Korea chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 240 Latin America chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
- TABLE 241 Latin America chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
- TABLE 242 Latin America chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 243 Latin America chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 244 Latin America chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 245 Latin America chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 246 Latin America chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 247 Latin America chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 248 Latin America chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 249 Latin America chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 250 Latin America chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 251 Latin America chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 252 Latin America chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 253 Latin America chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 254 Brazil chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 255 Brazil chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 256 Brazil chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 257 Brazil chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 258 Brazil chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 259 Brazil chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 260 Brazil chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 261 Brazil chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 262 Brazil chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 263 Brazil chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 264 Brazil chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 265 Brazil chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 266 Mexico chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 267 Mexico chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 268 Mexico chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 269 Mexico chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 270 Mexico chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 271 Mexico chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 272 Mexico chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 273 Mexico chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 274 Mexico chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 275 Mexico chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 276 Mexico chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 277 Mexico chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 278 Argentina chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 279 Argentina chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 280 Argentina chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 281 Argentina chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 282 Argentina chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 283 Argentina chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 284 Argentina chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 285 Argentina chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 286 Argentina chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 287 Argentina chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 288 Argentina chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 289 Argentina chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 290 MEA chronic venous occlusions treatment market, by country, 2017 - 2021 (USD Million)
- TABLE 291 MEA chronic venous occlusions treatment market, by country, 2022 - 2030 (USD Million)
- TABLE 292 MEA chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 293 MEA chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 294 MEA chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 295 MEA chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 296 MEA chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 297 MEA chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 298 MEA chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 299 MEA chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 300 MEA chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 301 MEA chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 302 MEA chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 303 MEA chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 304 South Africa chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 305 South Africa chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 306 South Africa chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 307 South Africa chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 308 South Africa chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 309 South Africa chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 310 South Africa chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 311 South Africa chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 312 South Africa chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 313 South Africa chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 314 South Africa chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 315 South Africa chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 316 Saudi Arabia chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 317 Saudi Arabia chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 318 Saudi Arabia chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 319 Saudi Arabia chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 320 Saudi Arabia chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 321 Saudi Arabia chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 322 Saudi Arabia chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 323 Saudi Arabia chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 324 Saudi Arabia chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 325 Saudi Arabia chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 326 Saudi Arabia chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 327 Saudi Arabia chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
- TABLE 328 UAE chronic venous occlusions treatment market, by product, 2017 - 2021 (USD Million)
- TABLE 329 UAE chronic venous occlusions treatment market, by product, 2022 - 2030 (USD Million)
- TABLE 330 UAE chronic venous occlusions treatment market, by devices, 2017 - 2021 (USD Million)
- TABLE 331 UAE chronic venous occlusions treatment market, by devices, 2022 - 2030 (USD Million)
- TABLE 332 UAE chronic venous occlusions treatment market, by endovenous ablation, 2017 - 2021 (USD Million)
- TABLE 333 UAE chronic venous occlusions treatment market, by endovenous ablation, 2022 - 2030 (USD Million)
- TABLE 334 UAE chronic venous occlusions treatment market, by drugs, 2017 - 2021 (USD Million)
- TABLE 335 UAE chronic venous occlusions treatment market, by drugs, 2022 - 2030 (USD Million)
- TABLE 336 UAE chronic venous occlusions treatment market, by application, 2017 - 2021 (USD Million)
- TABLE 337 UAE chronic venous occlusions treatment market, by application, 2022 - 2030 (USD Million)
- TABLE 338 UAE chronic venous occlusions treatment market, by end-use, 2017 - 2021 (USD Million)
- TABLE 339 UAE chronic venous occlusions treatment market, by end-use, 2022 - 2030 (USD Million)
Charts & Figures
- FIG. 1 Top-down approach
- FIG. 2 Breakdown of primary participants
- FIG. 3 Chronic venous occlusion treatment industry 360 degree synopsis, 2017 - 2030
- FIG. 4 Industry segmentation
- FIG. 5 Global chronic venous occlusion treatment market, 2017 - 2030 (USD Million)
- FIG. 6 Growth potential analysis, by product
- FIG. 7 Growth potential analysis, by application
- FIG. 8 Growth potential analysis, by end-use
- FIG. 9 Porter's Analysis
- FIG. 10 Company matrix analysis, 2021
- FIG. 11 PESTEL Analysis
- FIG. 12 Key segment trends, by product
- FIG. 13 Key segment trends, by application
- FIG. 14 Key segment trends, by end-use
- FIG. 15 Key regional trends
- FIG. 16 Strategy dashboard, 2021
